학술논문
Lecanemab, Aducanumab, and Gantenerumab — Binding Profiles to Different Forms of Amyloid-Beta Might Explain Efficacy and Side Effects in Clinical Trials for Alzheimer’s Disease
Document Type
Article
Author
Source
In: Neurotherapeutics . (Neurotherapeutics, January 2023, 20(1):195-206)
Subject
Language
English
ISSN
18787479
19337213
19337213